{
    "eid": "2-s2.0-85062853645",
    "title": "Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation",
    "cover-date": "2019-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Spectroscopy",
            "@code": "1607",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Physical and Theoretical Chemistry",
            "@code": "1606",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Computer Graphics and Computer-Aided Design",
            "@code": "1704",
            "@abbrev": "COMP"
        },
        {
            "@_fa": "true",
            "$": "Materials Chemistry",
            "@code": "2505",
            "@abbrev": "MATE"
        }
    ],
    "keywords": [
        "Asunaprevir resistance",
        "HCV NS3/4A protease",
        "Molecular dynamics simulation",
        "Principal component analysis"
    ],
    "authors": [
        "Jirayu Kammarabutr",
        "Panupong Mahalapbutr",
        "Bodee Nutho",
        "Nawee Kungwan",
        "Thanyada Rungrotmongkol"
    ],
    "citedby-count": 23,
    "ref-count": 54,
    "ref-list": [
        "Hepatitis C viral life cycle",
        "The mechanism of HCV entry into host cells",
        "Guidelines for the Screening, Care and Treatment of Persons with Chronic Hepatitis C Infection",
        "Global epidemiology and genotype distribution of the hepatitis C virus infection",
        "Global distribution and prevalence of hepatitis C virus genotypes",
        "A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals",
        "Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection",
        "Discovery of GS-9451: an acid inhibitor of the hepatitis C virus NS3/4A protease",
        "HCV genome and life cycle",
        "HCV NS2/3 protease",
        "The discovery and development of boceprevir: a novel, first-generation inhibitor of the hepatitis C virus NS3/4a serine protease",
        "SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells",
        "Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections",
        "Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus",
        "Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease",
        "In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450",
        "In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435",
        "In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor",
        "Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics",
        "Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor",
        "Danoprevir, a small-molecule NS3/4A protease inhibitor for the potential oral treatment of HCV infection",
        "Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease",
        "MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants",
        "Faldaprevir and deleobuvir for HCV genotype 1 infection",
        "Preclinical profile and characterization of the hepatitis C virus NS3 protease inhibitor asunaprevir (BMS-650032)",
        "The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection",
        "In vitro resistance profile of the hepatitis C virus NS3 protease inhibitor BI 201335",
        "Resistance analysis of the hepatitis C virus NS3 protease inhibitor asunaprevir",
        "The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors",
        "Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451",
        "Hepatitis C virus drug resistance associated substitutions and their clinical relevance: update 2018",
        "Protease inhibitor therapy for hepatitis C virus-infection",
        "Exploring resistance mechanisms of HCV NS3/4A protease mutations to MK5172: insight from molecular dynamics simulations and free energy calculations",
        "Understanding the drug resistance mechanism of hepatitis C virus NS3/4A to ITMN-191 due to R155K, A156V, D168A/E mutations: a computational study",
        "Molecular modeling study on the resistance mechanism of HCV NS3/4A serine protease mutants R155K, A156V and D168A to TMC435",
        "Structural analysis of asunaprevir resistance in HCV NS3/4A protease",
        "Dassault Syst\u00e8mes BIOVIA, Discovery Studio, 3.5, San Diego",
        "PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations",
        "An overview of the Amber biomolecular simulation package",
        "Amber 14",
        "Molecular insights into inclusion complexes of mansonone E and H enantiomers with various beta-cyclodextrins",
        "Key binding and susceptibility of NS3/4A serine protease inhibitors against hepatitis C virus",
        "Role of R292K mutation in influenza H7N9 neuraminidase toward oseltamivir susceptibility: MD and MM/PB(GB)SA study",
        "Potential energy functions for atomic-level simulations of water and organic and biomolecular systems",
        "Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models",
        "A stochastic algorithm for the isobaric-isothermal ensemble with Ewald summations for all long range forces",
        "Molecular dynamics, Monte Carlo simulations, and Langevin dynamics: a computational review",
        "Binding mode and free energy prediction of fisetin/beta-cyclodextrin inclusion complexes",
        "Computational screening of fatty acid synthase inhibitors against thioesterase domain",
        "Molecular and dynamic mechanism underlying drug resistance in genotype 3 hepatitis C NS3/4a protease",
        "Molecular dynamics and principal components analysis of human telomeric quadruplex multimers",
        "Effect of D168V mutation in NS3/4A HCV protease on susceptibilities of faldaprevir and danoprevir",
        "Computational study on the molecular mechanisms of drug resistance of Narlaprevir due to V36M, R155K, V36M+R155K, T54A, and A156T mutations of HCV NS3/4A protease",
        "Computational study on the drug resistance mechanism against HCV NS3/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Biochemistry",
        "Faculty of Science, CU",
        "Ratchadaphiseksomphot Endowment Fund",
        "Chiang Mai University",
        "Chulalongkorn University",
        "National Science and Technology Development Agency"
    ]
}